Details for Patent: 11,129,869

✉ Email this page to a colleague

Which drugs does patent 11,129,869 protect, and when does it expire?

Patent 11,129,869 protects IMCIVREE and is included in one NDA.

This patent has thirty-one patent family members in seventeen countries.

Summary for Patent: 11,129,869

Title:	Pharmaceutical compositions
Abstract:	The present invention relates to an ionic complex comprising a cationic polypeptide and an anionic excipient selected from: a PEG-carboxylic acid; a fatty acid having 10 or more carbon atoms; an anionic phospholipid; and a combination thereof. The invention also relates to a pharmaceutical composition comprising the ionic complex of the invention and a pharmaceutically acceptable carrier. The cationic polypeptide of the ionic complex has pharmacological activity and the complex can provide a more desirable pharmacokinetic profile for the cationic polypeptide of the complex as compared to the cationic polypeptide alone following administration. As such, the invention also relates to the use of the ionic complex and pharmaceutical composition comprising same to treat a subject suffering from a disease or disorder that is responsive to the cationic polypeptide of the ionic complex.
Inventor(s):	Sharma; Shubh (Cranbury, NJ), Van Der Ploeg; Leonardus H. T. (Newton, MA), Henderson; Bart (Belmont, MA)
Assignee:	RHYTHM PHARMACEUTICALS, INC. (Boston, MA)
Application Number:	14/775,911
Patent Claim Types: see list of patent claims	Composition; Compound; Process;

Drugs Protected by US Patent 11,129,869

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Rhythm	IMCIVREE	setmelanotide acetate	SOLUTION;SUBCUTANEOUS	213793-001	Nov 25, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 11,129,869

PCT Information
PCT Filed	March 14, 2014	PCT Application Number:	PCT/US2014/029421
PCT Publication Date:	September 18, 2014	PCT Publication Number:	WO2014/144842

International Family Members for US Patent 11,129,869

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2970389	⤷ Sign Up	301149	Netherlands	⤷ Sign Up
European Patent Office	2970389	⤷ Sign Up	CA 2021 00054	Denmark	⤷ Sign Up
European Patent Office	2970389	⤷ Sign Up	2021C/551	Belgium	⤷ Sign Up
European Patent Office	2970389	⤷ Sign Up	122021000083	Germany	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.